NYSE:CVS - CVS Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$75.08 -0.44 (-0.58 %)
(As of 11/21/2018 04:00 PM ET)
Previous Close$75.52
Today's Range$74.96 - $76.55
52-Week Range$60.14 - $83.88
Volume6.28 million shs
Average Volume7.50 million shs
Market Capitalization$80.03 billion
P/E Ratio12.73
Dividend Yield2.55%
Beta0.98
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Current SymbolNYSE:CVS
Previous Symbol
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio1.66
Current Ratio2.44
Quick Ratio1.94

Price-To-Earnings

Trailing P/E Ratio12.73
Forward P/E Ratio10.70
P/E Growth1.05

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.41
Cash Flow$8.2144 per share
Price / Cash9.14
Book Value$35.95 per share
Price / Book2.09

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins1.65%
Return on Equity18.69%
Return on Assets5.61%

Miscellaneous

Employees246,000
Outstanding Shares1,018,800,000
Market Cap$80.03 billion
OptionableOptionable

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Thursday, October 4th. Investors of record on Wednesday, October 24th will be paid a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Tuesday, October 23rd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. CVS Health's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.50 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

What price target have analysts set for CVS?

17 analysts have issued 1 year price objectives for CVS Health's shares. Their predictions range from $76.00 to $100.00. On average, they anticipate CVS Health's stock price to reach $90.9333 in the next year. This suggests a possible upside of 21.1% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Has CVS Health been receiving favorable news coverage?

Media stories about CVS stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news articles about the pharmacy operator a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next few days.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 58,223,127 shares, an increase of 0.2% from the October 15th total of 58,345,396 shares. Based on an average trading volume of 7,427,896 shares, the days-to-cover ratio is presently 7.8 days. Approximately 5.7% of the company's shares are short sold. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief of Policy & External Affairs Officer and Gen. Counsel (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%), Bank of New York Mellon Corp (1.23%), Franklin Resources Inc. (1.15%) and Veritas Asset Management LLP (1.15%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company , Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Bridgewater Associates LP and Mackenzie Financial Corp. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Which institutional investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Senator Investment Group LP, HealthCor Management L.P., FMR LLC and Point72 Asset Management L.P.. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $75.1050.

How big of a company is CVS Health?

CVS Health has a market capitalization of $80.03 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is http://www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  1,035 (Vote Outperform)
Underperform Votes:  553 (Vote Underperform)
Total Votes:  1,588
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel